How Do We Define Cure of Diabetes?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles ( 1) and commentaries ( 2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies [54–57] subdivided results as previously proposed by Buse et al. [58].”
The cited source says what the claim attributes to it.
In the citing paper
“Sustained improvements over two years were observed with high (74 %) retention, of whom 19 % achieved remission by the definition of Buse et al. [1] and 25 % according to the Riddle et al. 2021 international consensus definition [2].”
The cited source says what the claim attributes to it.
In the citing paper
“Firstly, the definition of remission of diabetes is the subject of considerable debate, specifically with regards to threshold levels of HbA1c/fasting glucose, use of diabetes medication, and the length of follow-up time meeting these criteria.60”
In the citing paper
“The Look AHEAD Trial, the Diabetes Remission Clinical Trial (DiRECT) and the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) highlighted the potential for T2DM remission, defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year, with a weight loss of 15 kg or more”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundCan Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundBarnes, E. (2007) · Chronic Illness · doi:10.1177/1742395307085333 · Cited by 17
Cited by
Items 801–900 of 1,000
Leyaro, B. J., Howie, L., Ali, A., & Carragher, R. (2026) · Obesity Facts · doi:10.1159/000552002 · Cited by 1
“This HbA1c threshold reflects a return to normal glycaemic level without glucose-lowering therapy and has been widely applied in previous bariatric surgery outcome studies [4, 9, 20].”
Treatment of the Metabolic Syndrome by Bariatric Surgery
Madsbad, S. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1331-8_14 · Cited by 1
ACTUALIZACIÓN DE CIRUGÍA BARIÁTRICA Y CIRUGÍA METABÓLICA
Álvarez, G., Fuentes, S., Mociulsky, J., Salinas, V., Yuma, M., Gutt, S., Ackerman, M., Lifszyc, P., & Espinoza, F. D. (2020) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v47i3.211 · Cited by 4
Minhem, M. A., Alami, R. S., & Safadi, B. Y. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00723-4 · Cited by 1
An Evaluation of Hemoglobin A1c Monitoring at a Student-Run Free Clinic in Kansas City, Missouri
Murali, M., Bodepudi, A., Casubhoy, I., & Kraemer, E. (2021) · Journal of Student-Run Clinics · doi:10.59586/jsrc.v7i1.232 · Cited by 1
Nachsorge nach bariatrischer Chirurgie: Aufgaben für die diabetologische Schwerpunktpraxis
Schultes, B. (2015) · Der Diabetologe · doi:10.1007/s11428-015-0002-4 · Cited by 1
The effect of bariatric surgery on obesity and its complications
Azmi, S., Alam, U., Ammori, B. J., Soran, H., & Malik, R. A. (2015) · Diabetes Management · doi:10.2217/dmt.15.32 · Cited by 1
Costa, A. C. C., Furtado, M. C. M. B., de Godoy, E. P., Pontes, E. R. J. C., de Souza, A. S., & Ivo, M. L. (2013) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/s0102-67202013000400013 · Cited by 1
Becker, T. S., Ronsoni, M. F., Hohl, A., & van de Sande‐Lee, S. (2014) · Clinical & Biomedical Research · doi:10.4322/2357-9730.50381 · Cited by 1
Genezing van diabetes mellitus type 2?
Reenders, K., & Verhoeven, S. (2013) · Huisarts en Wetenschap · doi:10.1007/s12445-013-0193-0 · Cited by 1
Predictive Factors of Insulin Resistance Resolution With Adjustable Gastric Band Surgery
Gutiérrez, P. C., Taghavi, M. K., Sosa-Medina, R. D., Cabezas, J. M. G., Gómez, V. J. O., Ruiz, J. L., & Setién, A. I. (2015) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2014.09.006 · Cited by 1
Gutiérrez, P. C., Taghavi, M. K., Sosa-Medina, R. D., Cabezas, J. M. G., Gómez, V. J. O., Ruiz, J. L., & Setién, A. I. (2014) · Cirugía Española · doi:10.1016/j.ciresp.2014.09.015 · Cited by 1
Bariatric surgery for the treatment of Type 2 diabetes: a step closer?
Chantziara, K., Laferrère, B., & Pi-Sunyer, X. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.894876 · Cited by 1
“[32], the term ‘remission of diabetes’ is neither clear-cut nor does it necessarily coincide with ‘cure’.”
BackgroundCirugía metabólica: a propósito de 3 casos
Talavera, D. P., Watt, M. P., & Ferreras, J. L. T. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.11.013 · Cited by 1
Scherbaum, W. A., & Nitschmann, S. (2013) · Der Internist · doi:10.1007/s00108-013-3274-z · Cited by 1
Rubio, M. Á., Monereo, S., Lecube, A., Resa, J., Masdevall, C., Goday, A., & Llorente, I. (2016) · Cited by 1
Postoperative Management of Obesity-Related Diseases
Augustin, T., & Rogers, A. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-43968-6_6 · Cited by 1
Weck, M. (2017) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-119075 · Cited by 1
“[13] Buse JB, Caprio S, Cefalu WT et al.”
BackgroundAbdelhafez, A. H. K., Taha, O., Abdelaal, M., Al‐Najim, W., le Roux, C. W., & Docherty, N. G. (2017) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2017.0042 · Cited by 3
Special Surgical Situations in Diabetes: Part 2
Kelkar, S., Muley, S., & Ambardekar, P. (2019) · Springer eBooks · doi:10.1007/978-981-13-7705-1_8 · Cited by 1
Moustafa, A. A., Sabry, K., Ibrahim, A., & Mohamed, M. (2019) · Ain Shams Medical Journal · doi:10.21608/asmj.2019.111359 · Cited by 1
Atalay, B. G., & Parlak, E. (2021) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2020.0099 · Cited by 1
Pokrovskaya, E. V., Sklyanik, I. A., Shestakova, E. A., & Shestakova, M. V. (2021) · Diabetes Mellitus · doi:10.14341/dm12716 · Cited by 1
Nasta, A. M., Goel, R., Goel, M., & Malek, A. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05570-z · Cited by 1
Ramos-Levi, A. M., & Rubio, M. Á. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.01.012 · Cited by 3
Artero, A., Martinez‐Ibañez, J., Civera, M., Martínez-Valls, J. F., Ortega, J., Real, J. T., & Ascaso, J. F. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.08.008 · Cited by 1
Davoudi, Z., Zahed, N. S., Tabatabaei, S.-S., Farsi, Y., Soori, M., & Mirhashemi, S. H. (2022) · Journal of Renal Injury Prevention · doi:10.34172/jrip.2022.32028 · Cited by 1
“5 %, in the absence of anti-diabetic medication (11).”
BackgroundEvidence Base for Bariatric Surgery
Almerie, Q., Leuratti, L., Khwaja, H. A., & Kerrigan, D. D. (2023) · Springer eBooks · doi:10.1007/978-3-030-60596-4_7 · Cited by 1
Alfonso Ballester, R., Kasyanchuk, I., Oliver, I. M., Fischer, G. K., Fernández, R. M., Rodríguez, M. L., Fernández, N. C., & Serrano, J. O. (2023) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2023.16.555940 · Cited by 1
Yu, C., Wang, Z., Wuyun, Q., Chen, W., Li, Z., Shang, M., & Zhang, N. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.05.012 · Cited by 1
Wysocki, M., Ciszek, K., Rymarowicz, J., Zarzycki, P., Walędziak, M. S., Bartosiak, K., Jaworski, P., Kupczyk, W., Szeliga, J., Tarnowski, W., et al. (2023) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-023-03102-0 · Cited by 2
“T2D remission definition was based on guidelines of American Diabetes Association (ADA), that is HBA 1c 6.0% without glucose-lowering pharmacotherapy and fasting glycemia within normal range [14, 15].”
MethodInfluentialPan, Y., Han, X., Tu, Y., Zhang, P., Yu, H., & Bao, Y. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07156-x · Cited by 1
“It was indicated by an HbA1c level < 6.0%, FPG level < 5.6 mmol/L, and non-use of hypoglycemic treatments for at least 1 year [17].”
InfluentialSilva, J. B. Q., Cebada, A. B., Escobar-Morreale, H. F., & Chávez, L. N. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.10.012 · Cited by 1
Barros, I. I. F., Paredes, S., Manso, F., da Costa, J., Fernandes, A., Alves, M., & Pereira, M. O. (2021) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ao200059 · Cited by 1
Kojima, M., Yamamoto, H., Ugi, S., Murata, S., Yamaguchi, T., Takebayashi, K., Tani, S., Maegawa, H., & Tani, T. (2013) · 日本消化器外科学会雑誌 · doi:10.5833/jjgs.2012.0191 · Cited by 1
Fulazzaky, T., & Fulazzaky, M. A. (2019) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2019.1.5.108 · Cited by 1
Recurrent Diabetes Following Bariatric Surgery: Incidence and Management
Chen, J., & Brethauer, S. A. (2020) · Current Surgery Reports · doi:10.1007/s40137-020-00268-0 · Cited by 1
The reversibility of type 2 diabetes
Steven, S. (2016) · Cited by 1
Machado, N. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-16042019-143104 · Cited by 4
Rubio-Almanza, M. (2019) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · doi:10.6035/14103.2019.664939 · Cited by 2
Sarathi, V. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac114 · Cited by 1
Li, S., Yu, H., Zhang, P., Tu, Y., Xiao, Y., Yang, D., Bao, Y., Han, J., & Jia, W. (2021) · doi:10.2337/figshare.16608080.v1 · Cited by 1
Li, S., Yu, H., Zhang, P., Tu, Y., Xiao, Y., Yang, D., Bao, Y., Han, J., & Jia, W. (2021) · doi:10.2337/figshare.16608080 · Cited by 1
The Impact of Obesity Intervention on Cancer: Clinical Perspectives
Adams, T. D., Greenwood, J. L. J., & Hunt, S. C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7660-3_9
The Role of Bariatric Surgery in Obese Patients with Diabetes: Primary or Rescue Therapy?
Gandikota, P., & Laferrère, B. (2011) · Wiley eBooks · doi:10.1002/9781444340280.ch14
Bariatric surgery and diabetes remission: how far have we progressed?
Singh, A. K., & Kota, S. K. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1073586
How and When Should Diabetes in the Obese Patient be Treated?
Busetto, L. (2012) · Springer eBooks · doi:10.1007/978-88-470-2634-6_7
Rubio, M. Á. (2014) · Avances en Diabetología · doi:10.1016/j.avdiab.2014.06.005 · Cited by 1
Goel, R. (2014) · Journal of Obesity and Metabolic Research · doi:10.4103/2347-9906.134414
El-Sayes, I., Weiner, R., Rad, M. T., Wolff, S., Knoll, C., Manger, T., & Stroh, C. (2013) · Surgical Science · doi:10.4236/ss.2013.412a002
“Remission, which can be either partial (improvement) or complete, was defined as achieving glycaemia below the diabetic range (126 mg/dl) in the absence of active pharmacologic (anti-hyperglycemic medications, immunosuppressive medications) or surgical (ongoing procedures such as repeated replacements of endoluminal d…”
BackgroundFried, M., & Yumuk, V. (2013) · Obesity Facts · doi:10.1159/000356090
Paull-Forney, B. G. (2014) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000222
“Additionally, this study’s definition of “optimal glycemic parameters” was identified based on the spirit of recommendations of a panel of experts convened by the American Diabetes Association (ADA) [12].”
BackgroundMerrill, A., & Jones, S. (2012) · JBI Library of Systematic Reviews · doi:10.11124/jbisrir-2012-36
Paciente con diabetes tipo 2 e índice de masa corporal 30-35kg/m2. La cirugía siempre debe esperar
Vilarrasa, N. (2014) · Avances en Diabetología · doi:10.1016/j.avdiab.2014.04.002
Metabolic surgery: Report of three cases
Talavera, D. P., Watt, M. P., & Ferreras, J. L. T. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.10.001
The Controversies Around Roux-en-Y Gastric Bypass
le Roux, C. W. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2834-2_31
Park, Y. S., Park, D. J., Jung, D. H., Son, S.-Y., Ahn, S. H., & Kim, H. (2014) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2014.3.1.11
Kan diabetes mellitus type 2 genezen?
Huls, M., van Dijk, M., & Boesten, M. (2015) · TvPO · doi:10.1007/s12503-015-0081-0
Etude de la voie des kynurénines dans l'obésité humaine
Favennec, M. (2015) · theses.fr (ABES) · doi:10.70675/5e430b60z7475z4c1ezaac8z2485e37a6c16
Revue de presse / Press review
Blanchard, C. L., Sterkers, A., & Genser, L. (2020) · Obésité · doi:10.3166/obe-2020-0091
Bariatric Surgery in the Therapy of Type 2 Diabetes Mellitus
Roslin, M. S., Goriparthi, R., Sabrudin, S. A., & Peristeri, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_55-1
Surgical treatment of severe obesity with laparoscopic gastric bypass and duodenal switch
Søvik, T. T. (2012) · NVA (Nasjonalt vitenarkiv)
Rabello, F. R. D. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-20052016-103421 · Cited by 4
Impact of bariatric surgeries on diabetes outcomes
Muscelli, E., & Alecrim, H. M. (2014)
de Cardiologia, P., & Paulo, S. (2016)
Rodriguez-Lopez, M. (2015) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/18750
RELATOS DAS AÇÕES EXTENSIONISTAS DA LIGA ACADÊMICA DO TRATO GASTROINTESTINAL E DOENÇAS METABÓLICAS
MONTIEL, E. M. S., Stumpf, M. A. M., OKAMOTO, J. M., Rodrigues, M. R. D. S., Kopruszynski, C. P., & SCHRUT, G. (2016) · Revista Conexao UEPG · doi:10.5212/rev.conexao.v.12.i3.0006 · Cited by 1
Type 2 diabetes mellitus (T2DM) onset and "remission".
Tangelloju, S. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2515 · Cited by 1
“17 Remission – Definition The American Diabetes Association (ADA) has proposed the following definitions for T2DM remission (106).”
BackgroundInfluentialType 2 diabetes mellitus remission after bariatric surgery in Hispanic patients from Costa Rica
Alfaro, M., Chen-Ku, C. H., & Ramos-Esquivel, A. (2017) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-017-0549-2
“7% and fasting glucose ≤100 mg/dl in the absence of diabetic medication [10].”
BackgroundAdami, G. F., & Cordera, R. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2735-1
“T2DM remission [26] might be a too stringent criterion: A close glucose control could lead to specific complications, and on the opposite hand a dyslipidemic status could support”
BackgroundKobal, P. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-05062017-164430 · Cited by 2
Genser, L., & Barrat, C. (2016) · Obésité · doi:10.1007/s11690-016-0517-x
Typ-2-Diabetes: bariatrische Chirurgie effektiver als medikamentöse Therapie
Stefan, N. (2017) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-111559
“182 Diabetologie 2017; 12 Referiert | kommentiert FAZIT Die 5-Jahres-Ergebnisse von Patienten mit Typ-2-Diabetes zeigen, dass die bariatrische Chirurgie in Hinblick auf die Gewichtsreduktion sowie die Verbesserung der glykämischen Kontrolle, der Lipidspiegel und der Lebensqualität einer alleinigen intensiven medikamen…”
BackgroundInfluentialEffetti metabolici della chirurgia bariatrica
Savastano, S., Barrea, L., Belcastro, S., & Broglio, F. (2017) · L Endocrinologo · doi:10.1007/s40619-017-0349-4
“Tabella 1 Criteri dell’American Diabetes Association (ADA) per la remissione del diabete (da [20]) Remissione parziale Glicemia a digiuno <5,6–6,9 mmol/L (100–125 mg/dl)”
BackgroundBile Acids and FGF19 in the Remission of Type 2 Diabetes After Sleeve Gastrectomy and Gastric Bypass
Nemati, R. (2017) · Tuwhera (Auckland University of Technology) · Cited by 1
Kleinwechter, H. J. (2017) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-123791
“1 Definition von Diabetesremission und Heilung nach Konsensus-Statement [3].”
BackgroundInfluentialIntensive Lifestyle Intervention for Type 2 Diabetes—Reply
Ried‐Larsen, M., Johansen, M. Y., & Pedersen, B. K. (2017) · JAMA · doi:10.1001/jama.2017.17240
Evolução da insulinorresistência em doentes submetidos a cirurgia bariátrica
Areias, M., Neves, O., Poínhos, R., Oliveira, B. M. P. M., & Correia, F. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
A Diabetes Mellitus tem Cura? - Caso Clínico
Luz, A. R., Pinto, A. C., & Ferreira, R. (2017) · Revista ADSO · doi:10.35323/revadso.57201777
Short‐Term Intensive Insulin Therapy in Patients with Newly Presenting Type 2 Diabetes
Xu, W., Owens, D. R., & Weng, J. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch33
Candian, D. C. F. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2018.tde-13062018-080600 · Cited by 2
Albaugh, V. L. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.09.011
Diabetes, Cinnamon and Green tea
Ataee, R. (2018) · Open Access Journal of Endocrinology · doi:10.23880/oaje-16000125
“Also it can induce many complications as diabetic ketoacidosis and non-ketotic-hyperosmolar coma which divided in two categories, insulin dependent (Type1), non-insulin dependent (Type2) which is in related to insensitivity of peripheral cells to insulin [1].”
Assal, K. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2018.tde-31102018-095604 · Cited by 1
Intensifying Lifestyle Management in Type 2 Diabetes Mellitus
Tan, H. H. (2018) · The Singapore Family Physician · doi:10.33591/sfp.44.5.u1
Type 2 diabetes mellitus in remission: An exploration
Chieng, V. Y., & Sampson, R. (2019) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738018816730
Diabetes in remissie: maar de voetzorg dan?
Stoeldraaijers, L., & van Putten, M. (2019) · PodoSophia · doi:10.1007/s12481-019-00228-3
The role of dialogic argumentation in science education for decision-making
Pezaro, C. (2018) · The University of Queensland · doi:10.14264/uql.2018.543
Remission of Type 2 Diabetes: A Challenge for Society and Health Care Professionals
Capaldo, B. (2018) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2018.06.555699
“5% and no antidiabetic medication use for at least 1 year; prolonged T2DM remission is defined as a complete remission extending beyond 5 years [6].”
BackgroundPrevention of diabetes through lifestyle intervention: effects on liver fat and brain
Drummen, M. (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190124md · Cited by 1
A Patient Loses 18 kg and Type 2 Diabetes Mellitus: The Challenge of Complete Remission
Odhaib, S. A., & Mansour, A. A. (2019) · Cureus · doi:10.7759/cureus.4817
Diyabette Leptin Hormonun Olası Etkileri
Taşkın, E., Güven, C., Kaya, S. T., & Sevgiler, Y. (2019) · Düzce Üniversitesi Bilim ve Teknoloji Dergisi · doi:10.29130/dubited.578925 · Cited by 1
Análisis de pacientes con diabetes tipo 2 en un centro de salud urbano. Estudio DESENROQUE
Hernández-Teixidó, C., Quirós, C., Bureo, C., Martínez, I. A., & Cabeza, F. C. (2019) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2019.05.012
Marrufo-Patrón, C. A., López-Rosales, F., & Hernández-Marín, J. D. (2019) · Cirugía y Cirujanos (English Edition) · doi:10.24875/cirue.m18000049
Hipoglikemia u pacjentów poddanych chirurgii metabolicznej — przegląd literatury
Szmygel, K., Hoffmann, M., Bigda, J., Kaska, Ł., Proczko-Stepaniak, M., & Narkiewicz, K. (2019) · Choroby Serca i Naczyń · doi:10.5603/chsin.2019.0040
Remisija diabetes mellitusa tipa 2 kod gojaznih pacijenata
Vidić, N., & Đenić, A. (2019) · Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma · doi:10.5937/medgla1975024v
Wobido, M. R., Dytz, D. V., Teixeira, R. C., Pignata, G. S., Dytz, O. D. C., & Dytz, M. G. (2015) · Brasília Médica · doi:10.5935/2236-5117.2015v52n3/4a06 · Cited by 1
Metadata
- Authors
- Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., Kahn, R., & Kirkman, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Pennington Biomedical Research Center (US)
- University of Warwick (GB)
- Department of Endocrinology & Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy;
- University of Nebraska–Lincoln (US)
- University of Rochester Medicine (US)
- Pacific Northwest Research Institute (US)
- NewYork–Presbyterian Hospital (US)
- American Diabetes Association (US)
- Corresponding author
- Kirkman, M. Sue
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2133-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768219
- OpenAlex
- W2138592519
- Cited by
- 1,003
- References
- 3
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 38 · 2023: 46 · 2022: 74 · 2021: 85 · 2020: 101 · 2019: 90 · 2018: 78 · 2017: 85 · 2016: 78 · 2015: 66 · 2014: 57 · 2013: 63 · 2012: 46
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes cure, diabetes remission, glycemic control, hyperglycemia, type 1 diabetes, type 2 diabetes, islet transplantation, pancreas transplantation, bariatric surgery, metabolic surgery, immunomodulation
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Status, Humans, Reference Values, Remission Induction, Societies, Medical, United States, Genetic Predisposition to Disease, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.